Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Drugs & Aging|November 24, 2020
Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the LiteratureMeital Oren-Shabtai, Noa Kremer, Moshe Lapidoth, et al.
Pigment Cell & Melanoma Research|September 19, 2017
Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanomaAlain P Algazi, Rosaura Esteve-Puig, Adi Nosrati, et al.
Pigment Cell & Melanoma Research|June 20, 2020
The role of technology in melanoma screening and diagnosisAlbert T Young, Niki B Vora, Jose Cortez, et al.
The Journal of Investigative Dermatology|July 23, 2018
Outcomes and Risk Factors in Patients with Multiple Primary MelanomasAdi Nosrati, Wesley Y Yu, Joseph McGuire, et al.
British Journal of Cancer|March 22, 2017
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapyAdi Nosrati, Katy K Tsai, Simone M Goldinger, et al.
JAMA Dermatology|February 28, 2017
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local ExcisionAdi Nosrati, Jacqueline G Berliner, Shilpa Goel, et al.
JCI Insight|July 21, 2017
Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapyKimberly Loo, Katy K Tsai, Kelly Mahuron, et al.
The Journal of Clinical Investigation|August 16, 2016
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanomaAdil I Daud, Kimberly Loo, Mariela L Pauli, et al.
Cancer Immunology Research|April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLCPaul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.
Pageof 2